R.PR
REGISTERED-PRINCIPAL REGISTER
04/12/2022
Back to search
Official data from USPTO
IPI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
04/12/2022
Trademark type
Combined
Nice classes
5
Filing date
03/27/2018
Registration date
04/12/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/12/2022
Last transaction
04/12/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/27/2020
First use in commerce
10/27/2020
Drawing code
3
Owner type
03
Owner location
Boston, MA
Examiner
DUBOIS, MICHELLE
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the letters "IPI" with two stylized letter "I"s. The first stylized "I" is a downward facing arrow and the second stylized "I" is an upward facing arrow. The non-arrow end of each stylized "I" is connected to the letter "P" using a thin curved line, where the top of the first stylized letter "I" is connected to the top of the "P" and the base of the second stylized letter "I" is connected to the base of the letter "P".
Holders and representatives
Holders
Institute for Protein Innovation, Inc.
Representatives
Trevor P. Schmidt Hutchison PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalsantibodies and antibody fragments for use in the prevention and treatment of disorders of metabolismthe nervous systemthe immune systemthe cardio-vascular systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; Pharmaceuticalsantibodies and antibody fragments for the treatment of fibrotic and inflammatory disorders; Pharmaceuticalsantibodies and antibody fragments for use in dermatologynephrologyhepatologyrheumatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Pharmaceuticalsantibodies and antibody fragments for use as antiviralanti-bacterialanti-fungal agents
Publications
History of USPTO decisions and trademark events.
55 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/08/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/07/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/23/2021
IUAF
USE AMENDMENT FILED
08/18/2021
EISU
TEAS STATEMENT OF USE RECEIVED
08/18/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/17/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/16/2021
EX5G
SOU EXTENSION 5 GRANTED
07/16/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/16/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/13/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/13/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/13/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/13/2021
EXT5
SOU EXTENSION 5 FILED
07/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/08/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/12/2021
EX4G
SOU EXTENSION 4 GRANTED
01/08/2021
EXT4
SOU EXTENSION 4 FILED
01/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/08/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/10/2020
EX3G
SOU EXTENSION 3 GRANTED
07/08/2020
EXT3
SOU EXTENSION 3 FILED
07/08/2020
EEXT
SOU TEAS EXTENSION RECEIVED
07/08/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/08/2020
EX2G
SOU EXTENSION 2 GRANTED
01/06/2020
EXT2
SOU EXTENSION 2 FILED
01/06/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/06/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/25/2019
EX1G
SOU EXTENSION 1 GRANTED
06/21/2019
EXT1
SOU EXTENSION 1 FILED
06/21/2019
EEXT
SOU TEAS EXTENSION RECEIVED
06/21/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/08/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/08/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/08/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/13/2018
PUBO
PUBLISHED FOR OPPOSITION
11/13/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/24/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/11/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/28/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/28/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/17/2018
GNRT
NON-FINAL ACTION E-MAILED
07/17/2018
CNRT
NON-FINAL ACTION WRITTEN
07/17/2018
DOCK
ASSIGNED TO EXAMINER
07/12/2018
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
04/17/2018
ALIE
ASSIGNED TO LIE
04/12/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/04/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/03/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/02/2018
NWAP
NEW APPLICATION ENTERED
03/30/2018
Continuous trademark protection
Get notified about every new filing that threatens IPI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.